AIG
NRIX icon

American International Group’s Nurix Therapeutics NRIX Stock Holding History

American International Group’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,460
Closed -$345K – 1785
2024
Q1 		$345K Sell
23,460
-201
-0.8% -$2.16K ﹤0.01% 1854
2023
Q4 		$244K Sell
23,661
-96
-0.4% -$658 ﹤0.01% 2071
2023
Q3 		$187K Buy
23,757
+1,204
+5% +$11K ﹤0.01% 2167
2023
Q2 		$225K Buy
22,553
+158
+0.7% +$1.61K ﹤0.01% 2092
2023
Q1 		$199K Buy
22,395
+446
+2% +$4.65K ﹤0.01% 2108
2022
Q4 		$241K Sell
21,949
-79
-0.4% -$953 ﹤0.01% 2035
2022
Q3 		$287K Buy
22,028
+1,276
+6% +$20.2K ﹤0.01% 1929
2022
Q2 		$263K Buy
20,752
+5,202
+33% +$59K ﹤0.01% 2005
2022
Q1 		$218K Sell
15,550
-1,094
-7% -$19.4K ﹤0.01% 2191
2021
Q4 		$482K Sell
16,644
-498
-3% -$15.1K ﹤0.01% 1834
2021
Q3 		$514K Sell
17,142
-408
-2% -$12.6K ﹤0.01% 1837
2021
Q2 		$466 Buy
17,550
+3,597
+26% +$106K ﹤0.01% 1969
2021
Q1 		$434 Buy
13,953
+7,181
+106% +$272K ﹤0.01% 1913
2020
Q4 		$223 Buy
6,772
+131
+2% +$4.34K ﹤0.01% 2222
2020
Q3 		$232K Buy
+6,641
New +$167K ﹤0.01% 2052

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

American International Group's NRIX Position: Q2 2024 in Review

American International Group sold out of Nurix Therapeutics (NRIX) in Q2 2024, closing a stake of 23,460 shares — an estimated $345K sold.

American International Group first reported a position in NRIX in Q3 2020 and held it in 15 quarters. The position peaked at $514K in Q3 2021. 173 funds tracked by Wall St. Rank hold NRIX as of Q2 2024.

  • American International Group reported no remaining Nurix Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 23,460 Nurix Therapeutics shares in Q2 2024, an estimated $345K.
  • American International Group first reported a position in Nurix Therapeutics in Q3 2020 and held it in 15 quarters.
  • American International Group's Nurix Therapeutics position peaked at $514K in Q3 2021.
  • 173 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.